Zobrazeno 1 - 10
of 567
pro vyhledávání: '"Jordan J, Feld"'
Autor:
Chelsea Masterman, Andrew B. Mendlowitz, Camelia Capraru, Karen Campbell, Genevieve Eastabrook, Mark H. Yudin, Tatyana Kushner, Jennifer A. Flemming, Jordan J. Feld, Yolanda Babenko-Mould, Panagiota Tryphonopoulos, Mia Biondi
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Stigma is a complex social phenomenon that leads to marginalization and influences the course of illness. In the context of hepatitis C virus (HCV), stigma is a well-documented barrier to accessing care, treatment, and cure. In re
Externí odkaz:
https://doaj.org/article/b461627e38d84e619a3b3129c3570455
Autor:
Zoë R Greenwald, Jordan J Feld, Dan Werb, Peter C Austin, Samantha Drover, Daniel Fridman, Ahmed Bayoumi, Tara Gomes, Claire E Kendall, Lauren Lapointe-Shaw, Ayden I Scheim, Sofia R Bartlett, Eric I Benchimol, Zachary Bouck, Christina Greenaway, Naveed Z Janjua, Pamela Leece, William WL Wong, Beate Sander, Jeffrey C Kwong
Publikováno v:
International Journal of Population Data Science, Vol 9, Iss 5 (2024)
Objective Health administrative data can support population-level research among people who inject drugs (PWID), however these data sources remain underutilized due to the difficulty in identifying drug use in routinely collected data. We validated c
Externí odkaz:
https://doaj.org/article/0d1bc83c8a704ef6805e9b51e5bd4cdf
Autor:
Mia J. Biondi, Mary Addo, Muhammad Atif Zahoor, Elsa Salvant, Paul Yip, Bethany Barber, David Smookler, Sumaiyah Wasif, Kayla Gaete, Christopher Kandel, Jordan J. Feld, Hubert Tsui, Robert A. Kozak
Publikováno v:
Pathogens, Vol 13, Iss 6, p 510 (2024)
Background: Post-acute sequelae of COVID-19, or long COVID, is a condition characterized by persistent COVID-19 symptoms. As long COVID is defined by clinical criteria after an elapsed period, an opportunity for early intervention may aid in future p
Externí odkaz:
https://doaj.org/article/09770aecf3444d19b3b9cf22fe999feb
Autor:
Nicole S Erler, Robert J de Knegt, Jordan J Feld, Bettina E Hansen, Harry L A Janssen, Adriaan J van der Meer, Christoph Welsch, Stefan Zeuzem, Amy Puenpatom, Thomas Vanwolleghem, Robert A de Man, Lisette A P Krassenburg, Raoel Maan, Stijn van Hees, Orlando Cerrhoci, Johannes Vermehren
Publikováno v:
BMJ Open Gastroenterology, Vol 10, Iss 1 (2023)
Background and aims Historical paired liver biopsy studies are likely to underestimate current progression of disease in patients with chronic hepatitis C virus (HCV) infection. We aimed to assess liver disease progression according to the non-invasi
Externí odkaz:
https://doaj.org/article/20684bd7459a42a999c55f58c9c6cca6
Autor:
Jeffrey V. Lazarus, Marcela Villota-Rivas, Pablo Ryan, Maria Buti, Lara Grau-López, Guillermo Cuevas, José Luis Espada, William Morón, Raul Felipe Palma-Álvarez, Jordan J. Feld, Jorge Valencia
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-11 (2023)
Abstract Background COVID-19 has hindered hepatitis C virus (HCV) and HIV screening, particularly in marginalised groups, who have some of the highest rates of these conditions and lowest rates of COVID-19 vaccination. We assessed the acceptability o
Externí odkaz:
https://doaj.org/article/36a027aa1f904a96bffb279cd63dd5ab
Autor:
Joanne M. Carson, Sebastiano Barbieri, Evan Cunningham, Eric Mao, Marc van derValk, Jürgen K. Rockstroh, Margaret Hellard, Arthur Kim, Sanjay Bhagani, Jordan J. Feld, Ed Gane, Maria C. Thurnheer, Julie Bruneau, Elise Tu, Gregory J. Dore, Gail V. Matthews, Marianne Martinello, the REACT study group
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 9, Pp n/a-n/a (2023)
Abstract Introduction Exploration of sexual and drug use behaviours following treatment for recent hepatitis C virus (HCV) is limited. This analysis modelled behavioural trajectories following treatment for recent HCV and assessed reinfection. Method
Externí odkaz:
https://doaj.org/article/b3262514476c4462adada919df457c2f
Autor:
Samuel C. Kim, Jeffrey J. Wallin, Yanal Ghosheh, Muhammad Atif Zahoor, Juan Diego Sanchez Vasquez, Shirin Nkongolo, Scott Fung, Patricia Mendez, Jordan J. Feld, Harry L.A. Janssen, Adam J. Gehring
Publikováno v:
JHEP Reports, Vol 5, Iss 9, Pp 100817- (2023)
Background & Aims: Novel therapies for chronic hepatitis B (CHB), such as RNA interference, target all viral RNAs for degradation, whereas nucleoside analogues are thought to block reverse transcription with minimal impact on viral transcripts. Howev
Externí odkaz:
https://doaj.org/article/c7aebf2062a9451e8b6acf89ff2a9203
Autor:
Deanna M. Santer, Daniel Li, Yanal Ghosheh, Muhammad Atif Zahoor, Dhanvi Prajapati, Bettina E. Hansen, D. Lorne J. Tyrrell, Jordan J. Feld, Adam J. Gehring
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
The interferon response is a critical component response to SARS-CoV-2 infection and prior studies have established a role for the administration of PEGylated interferon-lambda1 and its impact on viral clearance. Here the authors show that PEGylated
Externí odkaz:
https://doaj.org/article/76aeb35452c84e428bbee3f01d975611
Autor:
Shirin Nkongolo, Deeqa Mahamed, Adrian Kuipery, Juan D. Sanchez Vasquez, Samuel C. Kim, Aman Mehrotra, Anjali Patel, Christine Hu, Ian McGilvray, Jordan J. Feld, Scott Fung, Diana Chen, Jeffrey J. Wallin, Anuj Gaggar, Harry L.A. Janssen, Adam J. Gehring
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 1 (2023)
Accumulation of activated immune cells results in nonspecific hepatocyte killing in chronic hepatitis B (CHB), leading to fibrosis and cirrhosis. This study aims to understand the underlying mechanisms in humans and to define whether these are driven
Externí odkaz:
https://doaj.org/article/3de81f98e7904dffa98ecc61f04fe620
Autor:
Aaron Vanderhoff, David Smookler, Mia J. Biondi, Scott Enman, Tintin Fuliang, Sana Mahmood, Agustina Crespi, Maria Marquez, Rafique Van Uum, Lucy You, Brett Wolfson‐Stofko, Renee Logan, Erin LeDrew, Hemant Shah, Harry Janssen, Camelia Capraru, Elisa Venier, Jordan J. Feld
Publikováno v:
Hepatology Communications, Vol 7, Iss 1, Pp e2101-e2101 (2023)
Health care initiatives, such as hepatitis C virus (HCV) screening, have been greatly overshadowed by the corona virus disease 2019 (COVID‐19) pandemic. However, COVID‐19 vaccination programs also provide an opportunity to engage with a high volu
Externí odkaz:
https://doaj.org/article/9fe5d7143ef444ad98842f79dcaea412